For: | Cernea S, Onișor D, Roiban AL, Benedek T, Rat N. Metabolic dysfunction-associated steatotic liver disease-associated fibrosis and cardiac dysfunction in patients with type 2 diabetes. World J Cardiol 2024; 16(10): 580-594 [PMID: 39492975 DOI: 10.4330/wjc.v16.i10.580] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v16/i10/580.htm |
Number | Citing Articles |
1 |
Wei Wang, Charlie Cooper. Metabolic dysfunction-associated steatotic liver disease and type 2 diabetes: A dual threat to cardiac dysfunction progression. World Journal of Cardiology 2025; 17(1): 102467 doi: 10.4330/wjc.v17.i1.102467
|
2 |
Danusia Onișor, Andrada Larisa Roiban, Simona Cernea. Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes Patients—The Relationship with Platelets Indicators. Medicina 2024; 60(12): 2091 doi: 10.3390/medicina60122091
|